StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

bis(D-gluconato-O1,O2)zink

Zinc Gluconate

HCID 443445
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
4468-02-4
Standard-SMILES
O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.[Zn+2]
InChIKey
WHMDKBIGKVEYHS-IYEMJOQQSA-L
Summenformel
C12H22O14Zn
Durchschnittliche Molmasse
455,7 g/mol
Monoisotopische Masse
454,030097

Überblick

Zinc gluconate is a L-alpha-D-Hepp-(1->7)-L-alpha-D-Hepp-(1->3)-L-alpha-D-Hepp-(1->5)-alpha-Kdo.

Namen und Bezeichner

Bevorzugter Name
Zinc Gluconate
IUPAC
zinc bis((2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate)
Lokaler Name
bis(D-gluconato-O1,O2)zink
Englischer Name
Zinc gluconate
Summenformel
C12H22O14Zn
Molmasse
455.69

Namen und Synonyme

ZINC GLUCONATE4468-02-4Zincum gluconicumZinc D-gluconate (1:2)Bis(D-gluconato-O1,O2) zincZinc gluconate (USP)U6WSN5SQ1ZDTXSID20894125ZinkgluconaatRubozineZinc, bis(D-gluconato-kappaO1,kappaO2)-, (T-4)-Zeuterin
Weitere Namen anzeigen
RubozincZinc gluconatZinc dihexonatezinc(ii) gluconatebis(D-gluconato-O1,O2)zincAids002622Aids-002622Zinc complexGivobio G Zn
MaxiGuardOticClrandClnzPlaqClnzBlue ScorpionClunia EasyDentOraZnBig RichardMedique ColdEeze

Datenbank-Bezeichner

CAS
4468-02-4
PubChem CID
443445
DTXSID
DTXSID20894125
ChEMBL
CHEMBL3833377
ChEBI

Eigenschaften

Berechnete Struktureigenschaften

Polarare Oberfläche (TPSA)
283 Ų
H-Brücken-Donoren
10
H-Brücken-Akzeptoren
14
Frei drehbare Bindungen
8
Schwere Atome
27
Formalladung
0
Komplexität
165

Experimentelle und physikochemische Eigenschaften

Chemical ClassesOther Uses -> Food Additives
Cosmetics · 2 Einträge

Cosmetic ingredients (Zinc Gluconate) -> CIR (Cosmetic Ingredient Review)

Skin conditioning; Deodorant

Food AdditivesNUTRIENT SUPPLEMENT -> FDA Substance added to food
Color/FormPowder or granular
Solubilitymoderately soluble
Animal DrugsFDA approved animal drugs -> Active ingredient
Physical DescriptionSolid; [HSDB] White granular solid; [MSDSonline]

Physikochemische Eigenschaften

Schmelzpunkt
172 · 172-175 °C
Siedepunkt
319 °C · 319°C
Dichte
1.44 · 1.44[at 20℃]

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 5 Einträge

This chemical does not meet GHS hazard criteria for 14.7% (39 of 266) of reports.

Danger

H318 (81.6%): Causes serious eye damage [Danger Serious eye damage/eye irritation]

P264+P265, P273, P280, P305+P354+P338, P317, P391, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 266 reports by companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Regulatory Information · 3 Einträge

Chemical: Zinc, bis(D-gluconato-.kappa.O1,.kappa.O2)-, (T-4)-

REACH registered substance: Bis(D-gluconato-O1,O2)zinc (EC: 224-736-9)

Zinc, bis(D-gluconato-.kappa.O1,.kappa.O2)-, (T-4)-: Does not have an individual approval but may be used under an appropriate group standard

Other Safety InformationIMAP assessments - Zinc, bis(D-gluconato-O1,O2)-: Human health tier I assessment
Hazards Summary · 1 Eintrag

Generally regarded as safe (GRAS) for use as dietary supplement and nutrient; [HSDB] At oral doses of 47 mg/kg, volunteers complained of distorted perceptions and nausea or vomiting; Intravenous LD50 (mouse) = 23.7 mg/kg; Oral LD50 (mouse) = 1290 mg/kg; [ChemIDplus] May cause irritation; [MSDSonline] See Zinc.

FDA RequirementsThis substance is generally recognized as safe when used as a nutrient and/or dietary supplement in accordance with good manufacturing or feeding practice.
Special Reports · 5 Einträge

Zinc and Health. Current Bibliographies in Medicine 98-3. Public Services Division/National Library of Medicine. 3619 citations January, 1990-June, 1998. Available from: http://www.nlm.nih.gov/archive/20040831/pubs/cbm/zinc.html as of November 2, 1998.

Chemie und Industrie

Pharmakologische Informationen

ATC Code · 2 Einträge

A - Alimentary tract and metabolism

QA - Alimentary tract and metabolism

Bionecessity · 1 Eintrag

Recommended intakes may be increased and/or supplementation may be necessary in the following conditions (based on documented zinc deficiency): alcoholism; burns; cirrhosis of the liver; diabetes mellitus; eating disorders - anorexia nervosa, bulimia; gastrectomy; genetic disorders - celiac, Crohn's, diarrhea, sprue, ulcerative colitis; intestinal parasitism; malabsorption syndromes associated with pancreatic insufficiency - pancreatic disease, cystic fibrosis; renal diseases - nephrotic syndrome, renal failure, uremia; short bowel syndrome; skin disorders - exfoliative dermatoses, psoriasis; prolonged stress; prolonged trauma. /Zinc supplements/

Protein BindingPlease refer to DrugBank entry [DB01593]
Pharmacodynamics · 1 Eintrag

Zinc is an important mineral found in almost every cell in the human body. It promotes the activity of about 100 enzymes. Zinc deficiency is often associated with an increased risk of infection. When they are used to treat the common cold, zinc supplements may interfere with rhinovirus cleavage or adhesion and may play a role in protecting plasma membranes from microbial toxins and complement.

Mechanism of ActionAlthough the mechanism of action is not completely known, zinc supplementation may be used to increase immunity against viruses or may interfere with the replication of certain viruses, such as the human papillomavirus (HPV).
Biological Half-Life280 days
Metabolism/Metabolites · 2 Einträge

Please refer to DrugBank entry [DB01593]

Zinc can enter the body through the lungs, skin, and gastrointestinal tract. Intestinal absorption of zinc is controlled by zinc carrier protein CRIP. Zinc also binds to metallothioneins, which help prevent absorption of excess zinc. Zinc is widely distributed and found in all tissues and tissues fluids, concentrating in the liver, gastrointestinal tract, kidney, skin, lung, brain, heart, and pancreas. In the bloodstream zinc is found bound to carbonic anhydrase in erythrocytes, as well as bound to albumin, _2-macroglobulin, and amino acids in the the plasma. Albumin and amino acid bound zinc can diffuse across tissue membranes. Zinc is excreted in the urine and faeces. (L49)

Zugehörige Reaktionen

2
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 1178164
HRID 1178164als Produkt
Reaktionsgleichung von HRID 2371659
HRID 2371659als Edukt

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
CHEBI:29708
UNII
U6WSN5SQ1Z
EC Number
224-736-9
Nikkaji
J209.087B
Dampfdruck
0 Pa · 0Pa at 20℃
storage temp.
-20 °C · Store at -20°C
Löslichkeit
Soluble in water, practically insoluble in anhydrous ethanol and in methylene chloride.
Aggregatzustand
powder to crystal
Farbe
White to Almost white
Wasserlöslichkeit
100 g/ · Soluble in water 100g/ l.
Merck
14 · 14,4456
Kosmetik-Inhaltsstoffe Funktionen
ORAL CAREANTIMICROBIALSKIN CONDITIONINGDEODORANT
InChI
InChI=1/2C6H12O7.Zn/c2*7-1-2(8)3(9)4(10)5(11)6(12)13;/h2*2-5,7-11H,1H2,(H,12,13);/q;;+2/p-2/t2*2-,3-,4+,5-;/s3
InChIKey
WHMDKBIGKVEYHS-ATBKJFGMNA-L
SMILES
[C@H](O)([C@H](O)[C@H](O)CO)[C@@H](O)C(=O)O[Zn]OC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO |&1:0,2,4,8,17,19,21,23,r|
LogP
-7.41 at · -7.41 at 20℃
CAS Datenbank
4468 · 4468-02-4(CAS DataBase Reference)
EPA chemische Informationen
Zinc, bis(D-gluconato-.kappa.O1,.kappa.O2)-, (T-4)- (4468-02-4)

USEPA; Ambient Water Quality Criteria Doc: Zinc (1980) EPA 400/5-80-079

USEPA; Ambient Water Quality Criteria Doc: Zinc (1987) EPA 400/5-87-003

Arvidson, B. A Review of Axonal Transport of Metals. Toxicology 88: 1-14 (19994) Recent findings regarding axonal transport of metals, including zinc.

For more Special Reports (Complete) data for ZINC GLUCONATE (6 total), please visit the HSDB record page.

Clean Water Act Requirements · 3 Einträge

Toxic pollutant designated pursuant to section 307(a)(1) of the Clean Water Act and is subject to effluent limitations. /Zinc and compounds/

For total recoverable zinc the criterion-to protect freshwater aquatic life ... is 47 ng/l as a 24 hr average ... at hardnesses of 50, 100, and 200 mg/l as CaCO3 the concentration of total recoverable zinc should not exceed 180, 320, 570 ug/l at any time. /Soluble zinc salts/

For total recoverable zinc the criterion to protect saltwater aquatic life ... is 58 ug/l as a 24 hr average and the concentration should not exceed 170 ug/l at any time. /Soluble zinc salts/

Hazard Classes and CategoriesEye Dam. 1 (81.6%)
State Drinking Water Guidelines · 2 Einträge

(AZ) ARIZONA 5000 ug/l /Zinc/

(MN) MINNESOTA 2000 ug/l /Zinc/

Federal Drinking Water Guidelines · 2 Einträge

EPA 5000 ug/l /Zinc/

EPA 2000 ug/l /Zinc, Lifetime health advisory/

Sicherheit und Schutzausrüstung

Disposal Methods · 1 Eintrag

SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.

Minimum Risk LevelIntermediate Oral: 0.3 mg/kg/day (L134) Chronic Oral: 0.3 mg/kg/day (L134)

Toxikologische Informationen

TreatmentZinc poisoning is treated symptomatically, often by administering fluids such as water or milk, or with gastric lavage. (L49)
Interactions · 5 Einträge

Large doses of zinc may inhibit copper absorption in the intestine; zinc supplements should be taken at least 2 hours after the administration of copper supplements. /Zinc supplements/

Thiazide diuretics have been found to increase urinary zinc excretion. /Zinc supplements/

Concurrent use of large amounts of fiber, phosphorus, or phytates with zinc supplements may reduce zinc absorption by formation of nonabsorbable complexes; food containing fiber, phosphorus, or phytates should be taken at least 2 hours after zinc supplements. /Zinc supplements/

Some studies have found that folate can decrease the absorption of zinc, but not in the presence of excessive zinc; other studies have found no inhibition. /Zinc supplements/

For more Interactions (Complete) data for ZINC GLUCONATE (8 total), please visit the HSDB record page.

Health EffectsChronic exposure to zinc causes anemia, atazia, lethargy, and decreases the level of good cholesterol in the body. It is also believed to cause pancreatic and reproductive damage. (L49)
Exposure RoutesInhalation (L49) ; oral (L49) ; dermal (L49)
Toxicity Summary · 3 Einträge

The CIR Expert Panel concluded that the following 27 zinc salts are safe in cosmetics in the present practices of use and concentration described in this safety assessment when formulated to be non-irritating...Zinc Gluconate...

Safe for use in cosmetics, with qualifications

Anaemia results from the excessive absorption of zinc suppressing copper and iron absorption, most likely through competitive binding of intestinal mucosal cells. Unbalanced levels of copper and zinc binding to Cu,Zn-superoxide dismutase has been linked to amyotrophic lateral sclerosis (ALS). Stomach acid dissolves metallic zinc to give corrosive zinc chloride, which can cause damage to the stomach lining. Metal fume fever is thought to be an immune response to inhaled zinc. (L48, L49, A49)

Signs and Symptoms · 1 Eintrag

Ingestion of large doses of zinc causes stomach cramps, nausea, and vomiting. Acute inhalation of large amounts of zinc causes metal fume fever, which is characterized by chills, fever, headache, weakness, dryness of the nose and throat, chest pain, and coughing. Dermal contact with zinc results in skin irritation. (L49)

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Probable Routes of Human ExposureUse of zinc gluconate in therapeutic applications will result in exposure in humans. Its use in cold remedies will result in considerable oral exposure in humans. (SRC)

Regulatorische Informationen

FDA RequirementsThis substance is generally recognized as safe when used as a nutrient and/or dietary supplement in accordance with good manufacturing or feeding practice.
Clean Water Act Requirements · 3 Einträge

Toxic pollutant designated pursuant to section 307(a)(1) of the Clean Water Act and is subject to effluent limitations. /Zinc and compounds/

For total recoverable zinc the criterion-to protect freshwater aquatic life ... is 47 ng/l as a 24 hr average ... at hardnesses of 50, 100, and 200 mg/l as CaCO3 the concentration of total recoverable zinc should not exceed 180, 320, 570 ug/l at any time. /Soluble zinc salts/

For total recoverable zinc the criterion to protect saltwater aquatic life ... is 58 ug/l as a 24 hr average and the concentration should not exceed 170 ug/l at any time. /Soluble zinc salts/

State Drinking Water Guidelines · 2 Einträge

(AZ) ARIZONA 5000 ug/l /Zinc/

(MN) MINNESOTA 2000 ug/l /Zinc/

Federal Drinking Water Guidelines · 2 Einträge

EPA 5000 ug/l /Zinc/

EPA 2000 ug/l /Zinc, Lifetime health advisory/

Sicherheitsdaten

tsca
TSCA listed
hs_code
29181600
RTECS-Nr.
ZH3750000
Giftige Stoffe Daten
4468-02-4(Hazardous Substances Data)
FDA Pharmacological Classification · 4 Einträge

ZINC GLUCONATE

Copper Absorption Inhibitor [EPC]; Decreased Copper Ion Absorption [PE]

ZINCUM GLUCONICUM

Copper Absorption Inhibitor [EPC]; Decreased Copper Ion Absorption [PE]

Absorption, Distribution and Excretion · 4 Einträge

Please refer to DrugBank entry [DB01593]

Feces and urine

Stored primarily in skeletal muscle and bone.

Please refer to DrugBank entry [DB01593]

Verwendung und Herstellung

Uses · 6 Einträge

CIR ingredient: Zinc Gluconate

Used as dietary supplement and food additive; Also used in human and veterinary medicine; [HSDB] Used as a chelating agent, high alkalinity bottle cleanser, finish remover, and in the tanning and textile industries; [Merck Index]

Textiles (Fiber & Fabric Manufacturing) [Category: Industry]

Dietary supplement and food additive

MEDICATION

MEDICATION (VET)

Formulations/Preparations · 3 Einträge

Descote zinc gluconate: Microencapsulated beaded powder containing 25% zinc gluconate & 75% edible coating

USP powder, granular & direct compressible grades

USP21 powder & fine granular grades

Household ProductsInformation on 4 consumer products that contain Zinc gluconate in the following categories is provided:
Use ClassificationCosmetics -> Skin conditioning; Deodorant
General Manufacturing InformationZinc, bis(D-gluconato-.kappa.O1,.kappa.O2)-, (T-4)-: ACTIVE
Anwendungen · 1 Eintrag

Verwendenzinc gluconate helps maintain the skin in good condition and acts as a deodorant by preventing the growth of micro-organisms, such as bacteria, fungi or yeast, in a formulation. Zinc gluconate could also be effectively used in anti-acne products.

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

Gluconate solutionstrongly acidic type cation exchange resinCalciumgluconatD-GluconsureZinkoxidZinkhydroxidWasserNatriumgluconat